drugset
Drugs / Quadrivalent inactivated influenza vaccine (IIV)
last change Nov 2023 re-read 3 minutes ago

Quadrivalent inactivated influenza vaccine (IIV)

Vaccine

Developed for
influenza
Investigated by
National Institute of Allergy and Infectious Diseases (NIAID) · National Institutes of Health (NIH) · Stanford University

Trials 1

today NCT03898973 · Ph 4
2020202120222023202420252026
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 4 NCT03898973 Apr 2019 → Nov 2023 influenza Stanford University Withdrawn No outcome recorded Stop: Enrollment

Evidence & citations 3 cited values

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as Quadrivalent inactivated influenza vaccine (IIV) ClinicalTrials.gov intervention name — accepted as the source's own label NCT03898973 ↗
Modality Vaccine “quadrivalent inactivated influenza vaccine (IIV)” NCT03898973 ↗
Route Intramuscular “Intramuscular Injection. Participants will receive the inactivated flu vaccine into anterior quadriceps.” NCT03898973 ↗